01 29Merck Canada Inc.
01 41341567
02 42236591
03 42268433
04 42288038
05 42324467
06 42329474
07 52410662
01 1Boceprevir
02 28Boceprevir | Ribavirin plus Peginterferon alfa - 2b
01 1Capsule
02 28Capsule / Capsule / Powder for Solution for Inject
01 82016-10-31
02 42018-04-28
03 42018-12-16
04 42019-03-24
05 52021-07-19
06 42025-02-19
Patent Expiration Date : 2018-12-16
Date Granted : 2002-07-30
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 2268433
Filing Date : 1998-12-16
Strength per Unit : 200mg / 200mg, 80mcg / 0.5mL (108 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2018-12-16
Date Granted : 2002-07-30
Patent Expiration Date : 2025-02-19
Date Granted : 2008-02-19
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 1341567
Filing Date : 1981-01-07
Strength per Unit : 200mg / 200mg, 80mcg / 0.5mL (108 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2025-02-19
Date Granted : 2008-02-19
Patent Expiration Date : 2019-03-24
Date Granted : 2002-11-05
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 2324467
Filing Date : 1999-03-24
Strength per Unit : 200mg / 200mg, 80mcg / 0.5mL (108 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2019-03-24
Date Granted : 2002-11-05
Patent Expiration Date : 2018-04-28
Date Granted : 2003-07-29
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 2288038
Filing Date : 1998-04-28
Strength per Unit : 200mg / 200mg, 80mcg / 0.5mL (108 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2018-04-28
Date Granted : 2003-07-29
Patent Expiration Date : 2016-10-31
Date Granted : 2002-02-26
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 2329474
Filing Date : 1996-10-31
Strength per Unit : 200mg / 200mg, 80mcg / 0.5mL (108 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2016-10-31
Date Granted : 2002-02-26
Patent Expiration Date : 2018-12-16
Date Granted : 2002-07-30
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 2268433
Filing Date : 1998-12-16
Strength per Unit : 200mg / 200mg, 100mcg / 0.5mL (135 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2018-12-16
Date Granted : 2002-07-30
Patent Expiration Date : 2025-02-19
Date Granted : 2008-02-19
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 1341567
Filing Date : 1981-01-07
Strength per Unit : 200mg / 200mg, 100mcg / 0.5mL (135 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2025-02-19
Date Granted : 2008-02-19
Patent Expiration Date : 2019-03-24
Date Granted : 2002-11-05
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 2324467
Filing Date : 1999-03-24
Strength per Unit : 200mg / 200mg, 100mcg / 0.5mL (135 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2019-03-24
Date Granted : 2002-11-05
Patent Expiration Date : 2018-04-28
Date Granted : 2003-07-29
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 2288038
Filing Date : 1998-04-28
Strength per Unit : 200mg / 200mg, 100mcg / 0.5mL (135 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2018-04-28
Date Granted : 2003-07-29
Patent Expiration Date : 2016-10-31
Date Granted : 2002-02-26
Boceprevir, Interferon Alfa-2B
Brand Name : VICTRELIS TRIPLE
Patent Number : 2329474
Filing Date : 1996-10-31
Strength per Unit : 200mg / 200mg, 100mcg / 0.5mL (135 mcg / pen)
Dosage Form : Capsule / Capsule / Powder for Solution for Inject
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Injection
Patent Expiration Date : 2016-10-31
Date Granted : 2002-02-26
